An Updated Evaluation of Intrathecal IgG Synthesis Markers in Relation to Oligoclonal Bands.
blood-derived CSF molecules
cerebrospinal fluid (CSF) analysis
hyperbolic function
intrathecal synthesis markers
multiple sclerosis (MS)
oligoclonal bands (OCBs)
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
20 Jan 2023
20 Jan 2023
Historique:
received:
06
12
2022
revised:
29
12
2022
accepted:
16
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
12
2
2023
Statut:
epublish
Résumé
The aim was to evaluate the performance of the latest quantitative marker for intrathecal IgG synthesis and to compare it with other established markers used for the same purpose. We retrospectively applied Auer's and Reiber's intrathecal IgG synthesis formulae in a cohort of 372 patients under investigation for central nervous system demyelination who had undergone lumbar puncture and oligoclonal bands (OCBs) detection for demonstrating intrathecal IgG synthesis. A ROC analysis revealed Auer's formula had lower sensitivity (68%) compared to Reiber's formula (83%) and IgG index (89%), in our cohort of patients that exhibited normal to mildly elevated albumin quotients (4.48 ± 3.93). By excluding possible sources of errors, we assume that Auer's formula is less sensitive than other established tools for the "prediction" of the detection of OCBs in routine cerebrospinal fluid (CSF) analyses due to the mathematical model used. Given the ability of Reiber's hyperbolic formula to describe the blood-CSF IgG distribution across a wide range of blood-brain barrier functionality, its use and the use of similar formulae are recommended for the discrimination between CNS-derived and blood-derived molecules in clinical laboratories.
Identifiants
pubmed: 36766494
pii: diagnostics13030389
doi: 10.3390/diagnostics13030389
pmc: PMC9913896
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Neurol Sci. 1994 Apr;122(2):189-203
pubmed: 8021703
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Front Immunol. 2019 Mar 29;10:641
pubmed: 30984199
Cell Immunol. 1986 Aug;101(1):122-31
pubmed: 3091263
Mult Scler. 2008 Nov;14(9):1157-74
pubmed: 18805839
Arch Neurol. 1987 Jun;44(6):600-4
pubmed: 3579678
Mult Scler. 2017 Oct;23(11):1496-1505
pubmed: 27899552
Neurology. 2008 Mar 25;70(13 Pt 2):1079-83
pubmed: 17881717
PLoS One. 2014 Apr 02;9(4):e88680
pubmed: 24695382
J Clin Immunol. 2005 Jul;25(4):338-45
pubmed: 16133990
Clin Chim Acta. 1972 Mar;37:15-23
pubmed: 4623296
Eur J Neurol. 2006 Sep;13(9):913-22
pubmed: 16930354
Ann Neurol. 2005 Dec;58(6):840-6
pubmed: 16283615
Mult Scler. 2020 Jul;26(8):912-923
pubmed: 31066634
Biomolecules. 2022 Nov 15;12(11):
pubmed: 36421703
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Mult Scler. 2015 Jul;21(8):1013-24
pubmed: 25680984
Neurol Sci. 2017 Oct;38(Suppl 2):217-224
pubmed: 29030765
Ann Neurol. 2001 Jul;50(1):121-7
pubmed: 11456302
PLoS One. 2014 Feb 25;9(2):e89945
pubmed: 24651567
Brain. 1990 Oct;113 ( Pt 5):1269-89
pubmed: 2245296
Front Immunol. 2021 Jun 17;12:675307
pubmed: 34220821
Ann Clin Biochem. 1992 Jul;29 ( Pt 4):405-10
pubmed: 1642446
Clin Chim Acta. 2021 Feb;513:64-67
pubmed: 33316216
J Neurol. 2008 Oct;255(10):1508-14
pubmed: 18685917
Clin Chim Acta. 1989 May 31;181(3):265-72
pubmed: 2758680
Ann Clin Biochem. 1990 Sep;27 ( Pt 5):436-43
pubmed: 2281923
Clin Chim Acta. 1987 Mar 30;163(3):319-28
pubmed: 3581475
J Neuroimmunol. 2013 Oct 15;263(1-2):116-20
pubmed: 23916392
Arch Neurol. 2005 Jun;62(6):865-70
pubmed: 15956157
J Neuroimmunol. 2006 Nov;180(1-2):17-28
pubmed: 16945427
Scand J Clin Lab Invest. 1977 Sep;37(5):385-90
pubmed: 337459
Clin Chim Acta. 2019 Oct;497:153-162
pubmed: 31351929
Clin Chim Acta. 1990 Mar 15;187(3):297-308
pubmed: 2323069
Eur J Neurol. 2016 Apr;23(4):713-21
pubmed: 26806360
Methods Mol Biol. 2012;869:247-58
pubmed: 22585491
J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):897-902
pubmed: 8057110